{1}
##LOC[OK]##
{1}
##LOC[OK]##
##LOC[Cancel]##
{1}
##LOC[OK]##
##LOC[Cancel]##
Skip Navigation
www.ahrq.gov
search
home
whatsnew
collection
primers
glossary
newsletter
mypsnet
newsletter
The Collection
>
Prescribing for the elderly. Part I: Sensitivity of the elderly to adverse drug reactions.
Nolan L, O'Malley K. J Am Geriatr Soc. 1988;36:142-149.
This study reviewed existing evidence in order to evaluate the relationship between chronological age and
adverse drug reactions
. The authors provide a narrative summary and tables to illustrate trends noted in the more robust inpatient literature and the somewhat scarce outpatient literature for this relationship. Factors thought to contribute to adverse drug events are discussed, including multiple drug therapy, the presence of multiple disorders, severity of disease, and altered pharmacokinetics and pharmacodynamics. The findings suggest that elderly patients are not likely to experience an adverse reaction simply because of their age. Future studies must account for the factors more likely to impact poor outcomes with drug therapy.
PubMed citation
Related Resources
STUDY
Concealed renal insufficiency and adverse drug reactions in elderly hospitalized patients.
Corsonello A, Pedone C, Corica F, Mussi C, Carbonin P, Antonelli Incalzi R, for the Gruppo Italiano di Farmacovigilanza nell'Anziano (GIFA) Investigators. Arch Intern Med. 2005;165:790-795.
STUDY
Predicting and preventing adverse drug reactions in the very old.
Merle L, Laroche ML, Dantoine T, Charmes JP. Drugs Aging. 2005;22:375-392.
STUDY
Use of the Beers criteria to predict adverse drug reactions among first-visit elderly outpatients.
Chang CM, Liu PY, Yang YH, Yang YC, Wu CF, Lu FH. Pharmacotherapy. 2005;25:831-838.
STUDY
Inappropriate drug use in the elderly: a nationwide register-based study.
Johnell K, Fastbom J, Rosén M, Leimanis A. Ann Pharmacother. 2007;41:1243-1248.
View all related resources...
Download:
Adobe Reader
Email
Find Related Resources by...
Resource Type
Review
Target Audience
Physicians
Pharmacists
Clinical Area
Geriatrics
Safety Target
Side Effects/Adverse Drug Reactions
Origin/Sponsor
United Kingdom